Botensilimab Recruiting Phase 1 / 2 Trials for Cancer, Advanced Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT03860272Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer
NCT04121676Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patient With Advanced Cancer